Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 996 results for "glaxo"

GSK starts Ebola vaccine trials this week

HUMAN trials start this week on an Ebola vaccine developed by GlaxoSmithKline, the UK pharmaceutical giant with a regional office in Nairobi. The candidate vaccine is expected to be given to healthy volunteers in the UK, Gambia and Mali to test ... The Star (Kenya), 6 hours ago
GSK to start Ebola vaccine trials Pharma Field, 1 hour ago

390 images for glaxo

Bio Spectrum Asia, 7 hours ago
Yahoo! UK and Ireland, 1 day ago
Epoch Times, 4 hours ago
Miami Herald, 6 hours ago
Livemint.com, 1 day ago
Pharmacy.Biz, 4 days ago
PM News Nigeria, 4 days ago
Malay Mail, 3 days ago
NDTV, 5 days ago
Philly.com, 4 days ago

Ligand Pharmaceuticals: FDA to OK GlaxoSmithKline Promacta/Revolade [Health & Beauty Close - Up]

[September 02, 2014] (Health & Beauty Close - Up Via Acquire Media NewsEdge) Ligand Pharmaceuticals reported that its partner GlaxoSmithKline has received approval of a supplemental New Drug Application for the once-daily use of ...
 TMC Net9 hours ago Prosonix' Marketing Authorisation Application for PSX1001 - a Generic Version of GlaxoSmithKline's Flixotide┬« Evohaler┬« - Under Assessment in EU  Vision Monday7 hours ago FDA approves GlaxoSmithKline's anaemia drug Promacta  Pharmaceutical Business Review6 days ago GlaxoSmithKline Receives FDA Approval Of An Additional Promacta┬« (Eltrombopag) Indication For Use In Patients With Severe Aplastic Anaemia (SAA) Who Have Had An Insufficient Response To Immunosuppressive Therapy (IST)  BioSpace6 days ago
[x]  
Business Standard India

Cipla zooms 9% on launch of generic asthma drug in Germany, Sweden

The pharmaceutical firm launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair. SI Reporter | Mumbai September 2, 2014 Last Updated at 09:30 IST Cipla has rallied nearly 9% to Rs 575, also its ...
 Business Standard India5 hours ago Cipla Ltd. Takes A Bite Out Of GlaxoSmithKline's Profits As Copy Of Top Asthma Drug Lauches In Germany, Sweden  BioSpace2 hours ago Cipla launches asthma drug in Germany, Sweden  Hindu Business Line1 day ago Cipla launches generic version of GlaxoSmithKline's Advair in Germany, Sweden  FirstWord Pharma1 day ago
[x]  
Bio Spectrum Asia

GSK China scandal: Chairman urged to resign

Singapore: Even though the chairman of British drug major GlaxoSmithKline had announced that he would be resigning in 2015, the dropping share price and ever mounting allegations in its Chinese bribery scandal have led to a mass rebellion. The ...
 Bio Spectrum Asia7 hours ago GSK shareholders want chairman to resign  Invezz3 hours ago GSK's chairman urged to resign earlier over China bribery scandal  BullBearings1 day ago
[x]  
Yahoo! UK and Ireland

My Favourite 5%+ Yields: GlaxoSmithKline plc, Centrica PLC & Vodafone Group plc

Although there has been a lot of talk recently regarding interest rate rises, it seems clear that rates are unlikely to hit the 'historic norm' of 4%-5% for many years to come. Indeed, the Bank of England has even stated that 2%-3% could be the 'new ...
 Yahoo! UK and Ireland8 hours ago
NDTV Profit

Cipla Soars Over 8% on Launch of Anti-Asthma Inhaler

Cipla shares rose as much as 8.7 per cent on Tuesday after the drugmaker launched a generic version of GlaxoSmithKline's anti-asthma inhaler Advair in Germany and Sweden. Cipla is the first company to launch a generic version of the inhaler in these ...
 NDTV Profit11 hours ago Cipla hits record high  Capital Market8 hours ago Cipla shares rally on anti-asthma inhaler launch in Germany  Oneindia9 hours ago Cipla zooms 9% on launching launching generic respiratory drug in Germany, Sweden  Smart Investor11 hours ago
[x]  

Germany oral care market led by GlaxoSmithKline with a 26% share in 2013

Even though Germany faces a rather stagnant development in population, with a continuously increasing average age, oral care keeps growing significantly in value and even slightly in volume sales terms. This is mostly due to the fact that in modern ...
 TransWorldNews15 hours ago

Ebola Vaccine: First-Ever Human Trials For Experimental Drug To Begin Soon

An experimental Ebola vaccine developed by GlaxoSmithKline plc (NYSE:GSK) in collaboration with the National Institute of Allergy and Infectious Diseases, or NIAID, will be tested on human volunteers later this week, according to a statement ...
 International Business Times8 hours ago Testing on Experimental Ebola Vaccine to Begin in U.S.  Investors Hub2 hours ago
Business Standard

Cipla Targets U.S. With Glaxo's Advair, Anti-AIDS Drugs

Cipla Ltd. (CIPLA) shot to prominence a decade ago by selling AIDS drugs for $1 a day in Africa. Now the Indian generics maker is seeking a bigger slice of the U.S. market with cheaper medicines for asthma and HIV. Cipla's top target is a version ...
 Bloomberg1 day ago Cipla targets US with Glaxo's Advair  Smart Investor13 hours ago Cipla eyes entry to US market with cheaper treatment for asthma  BDlive10 hours ago
[x]  

PRESS: Glaxo Shareholders Call For Chairman Change This Year

[September 01, 2014] (Alliance News Via Acquire Media NewsEdge) LONDON (Alliance News) - GlaxoSmithKline PLC faces a potential shareholder revolt from investors calling for Chairman Chris Gent to leave more quickly, the Sunday ...
 TMC Net1 day ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less